Merchant & Gould IP Case Updates Blog

The Federal Circuit recently reversed a post-verdict JMOL of invalidity in Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, No. 2024-1094 (Fed. Cir. Apr. 16, 2026), highlighting the deference owed to jury verdicts supported by substantial evidence.

The decision offers important guidance for litigants regarding the application of written description and enablement under 35 U.S.C. § 112 to method claims involving a well-known genus and routine techniques.

Read more in this blog post by Alana LeFebvre: https://na2.hubs.ly/H05c9HZ0

Recently, the U.S. Court of Appeals for the Second Circuit issued an opinion in Vans, Inc. v. MSCHF Product Studio, Inc., No. 22-1006 (Dec. 5, 2023), affirming the district court’s grant of a temporary restraining order (TRO) and preliminary injunction enjoining MSCHF’s use of Vans’ trademark and trade dress in its Wavy Baby sneakers.

Read the full case summary by Rachel Zimmerman Scobie on the M&G IP Case Updates Blog. 🔗https://hubs.la/Q02djtFY0